Glenmede Trust’s Mead Johnson Nutrition Company MJN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-29,754
| Closed | -$2.65M | – | 2962 |
|
|
2017
Q2 | $2.65M | Hold |
29,754
| – | – | 0.01% | 593 |
|
|
2017
Q1 | $2.65M | Buy |
29,754
+945
| +3% | +$77.7K | 0.01% | 593 |
|
|
2016
Q4 | $2.04M | Sell |
28,809
-6,673
| -19% | -$497K | 0.01% | 623 |
|
|
2016
Q3 | $2.8M | Sell |
35,482
-10,047
| -22% | -$857K | 0.02% | 556 |
|
|
2016
Q2 | $4.13M | Buy |
45,529
+8,888
| +24% | +$753K | 0.03% | 484 |
|
|
2016
Q1 | $3.11M | Sell |
36,641
-11,294
| -24% | -$840K | 0.02% | 519 |
|
|
2015
Q4 | $3.78M | Buy |
47,935
+19,828
| +71% | +$1.56M | 0.03% | 478 |
|
|
2015
Q3 | $1.98M | Hold |
28,107
| – | – | 0.01% | 593 |
|
|
2015
Q2 | $2.54M | Buy |
28,107
+2,191
| +8% | +$211K | 0.02% | 530 |
|
|
2015
Q1 | $2.6M | Hold |
25,916
| – | – | 0.02% | 538 |
|
|
2014
Q4 | $2.6M | Sell |
25,916
-3,573
| -12% | -$356K | 0.02% | 519 |
|
|
2014
Q3 | $2.84M | Buy |
29,489
+3,247
| +12% | +$308K | 0.02% | 482 |
|
|
2014
Q2 | $2.44M | Sell |
26,242
-7,509
| -22% | -$657K | 0.02% | 517 |
|
|
2014
Q1 | $2.81M | Buy |
33,751
+1,895
| +6% | +$154K | 0.03% | 500 |
|
|
2013
Q4 | $2.67M | Buy |
31,856
+19,219
| +152% | +$1.56M | 0.03% | 497 |
|
|
2013
Q3 | $937K | Sell |
12,637
-440
| -3% | -$33K | 0.01% | 670 |
|
|
2013
Q2 | $1.04M | Buy |
+13,077
| New | +$1.05M | 0.01% | 621 |
|
Other funds holding MJN
Glenmede Trust's MJN Position: Q3 2017 in Review
Glenmede Trust sold out of Mead Johnson Nutrition Company (MJN) in Q3 2017, closing a stake of 29,754 shares — an estimated $2.65M sold.
Glenmede Trust first reported a position in MJN in Q2 2013 and held it in 17 quarters. The position peaked at $4.13M in Q2 2016. 1 fund tracked by Wall St. Rank holds MJN as of Q3 2017.
- Glenmede Trust reported no remaining Mead Johnson Nutrition Company position as of Q3 2017 after selling out during the quarter.
- Glenmede Trust sold 29,754 Mead Johnson Nutrition Company shares in Q3 2017, an estimated $2.65M.
- Glenmede Trust first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 17 quarters.
- Glenmede Trust's Mead Johnson Nutrition Company position peaked at $4.13M in Q2 2016.
- 1 fund tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q3 2017.
Based on Glenmede Trust's 13F filing for Q3 2017, filed 14 Nov 2017.